Sign in: Staff/Students
Professor Sir Munir Pirmohamed
Professor Sir Munir Pirmohamed, from the University’s Institute of Translational Medicine, has been named as President Elect of the British Pharmacological Society for two years after which he will become President in 2020.
The British Pharmacological Society is a charity with a mission to promote and advance the whole spectrum of pharmacology. The Society leads the way in the research and application of pharmacology around the world.
Sir Munir, who is also Consultant Physician at the Royal Liverpool University Hospital, holds the only NHS Chair in Pharmacogenetics in the UK and is Director of the Medical Research Council’s Centre for Drug Safety Sciences.
His research, which spans the whole spectrum from discovery to implementation, focuses on individual variability in drug response, including anti-cancer drugs, with a view to evaluating the mechanisms and identifying strategies to personalise healthcare.
Of the award Sir Munir said: “I am honoured to have been elected to this prestigious position, and I am looking forward to playing such a significant role in promoting the BPS, its members and the field of pharmacological research around the world.
“This honour not only recognises my work, but also the efforts of the whole team at the University of Liverpool. It is also further recognition of our Department of Molecular and Clinical Pharmacology, which was recently awarded the Queen’s Anniversary Prize.”
The formal announcement of his appointment was made at the Society’s AGM on 12 December 2017, during its flagship annual meeting, Pharmacology 2017.
Jonathan Bruun, Chief Executive of the Society, said: “I am delighted to see Munir elected to this role. For the past six years he has served the Society as Vice-President – Clinical, during which time he has led the campaign to build the profile of clinical pharmacology in the NHS. Munir’s track record of leadership on this issue and the high regard in which is he held in both medicine and academia – and by health policymakers – makes him the ideal person for this important position, and to take on the Presidency in two years’ time.
“Munir is already one of our most authoritative and articulate advocates, and I look forward to working with him even more closely over the next two years.”
To read more about Sir Munir’s research please visit https://www.liverpool.ac.uk/translational-medicine/staff/munir-pirmohamed/ or to listen to his podcast about personalised medicine visit here.
For more information about The British Pharmacological Society please visit www.bps.ac.uk
You must be logged in to post a comment.
All recent news
Lateral flow tests detect most people at risk of transmitting Covid-19
Free digital skills training for Liverpool students
Social disadvantage in the UK has a lasting impact on childhood asthma
Win a year’s tuition fees with Santander Universities UK
How to share your feedback with us – Student Feedback Hub
Professor Eithne Costello from @LivUni on the link between Type 2 Diabetes and Pancreatic Cancer #ITVTonight at 8pm.
Professor Chris Holloran of The University Of Liverpool (@LivUni) explains the importance of diagnosing Pancreatic Cancer early.
You can watch the full episode on #ITVTonight at 8pm
Researchers from @LivCancerRes feature in a new @ITVTonight film about #PancreaticCancer.
Profs Chris Halloran & Eithne Costello discuss the importance of early detection & the research taking place to help to improve outcomes.
📺 Watch 'Britain's Hidden Killer' on ITV at 8pm.